Table 3 Clinical outcomes at last follow-up of the included studies
Study | Type of prosthesis | VAS improvement rate (%) | ODI score improvement | Clinical success rate (%) | Satisfaction rate (%) |
|---|---|---|---|---|---|
Guyer et al. [17] | Charité | 55.7 | − 21.5 | 57.8 | 78.0 |
Zigler and Delamarter [50] | ProDisc | 51.1 | − 44.4 | 53.7 | NA |
Van De Kelft and Verguts. [43] | Maverick | 61.0 | − 28.55 | 63.0 | 77.0 |
Meir et al. [27] | AcroFlex | NA | − 15.6 | NA | NA |
Sköld et al. [41] | Charité, ProDisc, Maverick | 63.6 | − 24.6 | 72.5 | 79.0 |
Siepe et al. [39] | ProDisc | 54.9 | NA | NA | 86.3 |
Tohmeh and Smith [42] | XL TDR | NA | NA | NA | 93.3 |
Laugesen et al. [20] | ProDisc | 52.9 | NA | NA | NA |
Putzier et al. [34] | Charité | NA | NA | NA | 75.5 |
David [7] | Charité | NA | NA | NA | NA |
Park et al. [29] | ProDisc | 70.5 | − 25.1 | 71.4 | 88.6 |
Lu et al. [23] | Charité | 82.8 | − 28.2 | 87.5 | NA |
Park et al. [31] | ProDisc | 57.0 | − 19.1 | 66.7 | 87.2 |